Rational Design and Synthesis of Enzyme Inhibitors: Significance in Probing the Function of Enzymes

ChemInform ◽  
2003 ◽  
Vol 34 (15) ◽  
Author(s):  
Jun Hiratake
2019 ◽  
Author(s):  
Andrea Testa ◽  
Scott J. Hughes ◽  
Xavier Lucas ◽  
Jane E. Wright ◽  
Alessio Ciulli

Constraining a molecule in its bioactive conformation via macrocyclization represents an attractive strategy to rationally design functional chemical probes. While this approach has been applied to enzyme inhibitors or receptor antagonists, to date it remains unprecedented for bifunctional molecules that bring proteins together, such as PROTAC degraders. Here, we report the design and synthesis of a first macrocyclic PROTAC by adding a second cyclizing linker to the BET degrader MZ1. A co-crystal structure of macroPROTAC-1 bound in a ternary complex with VHL and the second Brd4 bromodomain validated the rational design. Biophysical studies revealed enhanced discrimination between the second and the first bromodomains of BET proteins. Despite a 12-fold loss of binary binding affinity for Brd4, macroPROTAC-1 exhibited cellular activity comparable to MZ1. Our findings support macrocyclization as an advantageous strategy to enhance PROTAC degradation potency and selectivity between homologous targets.


2019 ◽  
Author(s):  
Andrea Testa ◽  
Scott J. Hughes ◽  
Xavier Lucas ◽  
Jane E. Wright ◽  
Alessio Ciulli

Constraining a molecule in its bioactive conformation via macrocyclization represents an attractive strategy to rationally design functional chemical probes. While this approach has been applied to enzyme inhibitors or receptor antagonists, to date it remains unprecedented for bifunctional molecules that bring proteins together, such as PROTAC degraders. Here, we report the design and synthesis of a first macrocyclic PROTAC by adding a second cyclizing linker to the BET degrader MZ1. A co-crystal structure of macroPROTAC-1 bound in a ternary complex with VHL and the second Brd4 bromodomain validated the rational design. Biophysical studies revealed enhanced discrimination between the second and the first bromodomains of BET proteins. Despite a 12-fold loss of binary binding affinity for Brd4, macroPROTAC-1 exhibited cellular activity comparable to MZ1. Our findings support macrocyclization as an advantageous strategy to enhance PROTAC degradation potency and selectivity between homologous targets.


2019 ◽  
Author(s):  
Andrea Testa ◽  
Scott J. Hughes ◽  
Xavier Lucas ◽  
Jane E. Wright ◽  
Alessio Ciulli

Constraining a molecule in its bioactive conformation via macrocyclization represents an attractive strategy to rationally design functional chemical probes. While this approach has been applied to design enzyme inhibitors or receptor antagonists, to date it remains unprecedented for bifunctional molecules that bring proteins together, such as PROTAC degraders. Here, we report the design and synthesis of a first macrocyclic PROTAC based on co-crystal structure of a parent linear molecule, by adding a cyclizing linker. A co-crystal structure of the macrocyclic PROTAC bound in a ternary complex with VHL and Brd4 validated the rational design and identified new interactions formed by the new linker. Biophysical studies revealed that the macrocycle selectively discriminated the second against the first bromodomains of BET proteins, and is a potent Brd4 degrader. Macrocyclization provides a viable strategy to induce protein-protein complexes and protein degradation inside cells.


2020 ◽  
Vol 85 (16) ◽  
pp. 10552-10560
Author(s):  
Peng Sang ◽  
Yan Shi ◽  
Pirada Higbee ◽  
Minghui Wang ◽  
Sami Abdulkadir ◽  
...  

2012 ◽  
Vol 22 (2) ◽  
pp. 73-74 ◽  
Author(s):  
Alexey A. Zeifman ◽  
Ilya Yu. Titov ◽  
Igor V. Svitanko ◽  
Tatiana V. Rakitina ◽  
Aleksey V. Lipkin ◽  
...  

Carbon ◽  
2021 ◽  
Author(s):  
Yajuan Zhao ◽  
Haolin Lyu ◽  
Yujie Liu ◽  
Wenjie Liu ◽  
Yong Tian ◽  
...  

1999 ◽  
Vol 274 (14) ◽  
pp. 9587-9599 ◽  
Author(s):  
Sandeep Mahajan ◽  
Sutapa Ghosh ◽  
Elise A. Sudbeck ◽  
Yaguo Zheng ◽  
Suzanne Downs ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document